Calendar

AAR has strong company-reported growth and FY2027 guidance, but the checked sources did not verify positive current-quarter estimate revisions or a revenue-upside signal, and the stock fell sharply into the event with weak close locations; operating momentum alone does not overcome the tape and evidence gaps.

AutoZone has credible upcoming EPS and revenue estimates, positive recent operating momentum, and a modest three-month revenue-estimate increase, but EPS estimates drifted lower and the stock sold off sharply into the event while XLY weakened; the tape does not support an upside-surprise setup.

Thor has a credible consensus EPS and revenue source and some resilient motorized and European demand, but both EPS and revenue estimates were revised lower, management cut full-year EPS guidance, the stock fell sharply into earnings, and XLY was weak; this is a cyclical turnaround watch rather than a pre-earnings surprise setup.

KB Home has a recent built-to-order catalyst, a positive five-session bounce, a strong close location, and above-normal volume, but accessible estimates imply sharply lower year-over-year EPS and revenue, estimate revisions were not available, housing-sector tape was weak, and the latest EPS miss keeps this below the surprise threshold.

Ferguson has solid recent operating execution and credible consensus EPS and revenue estimates, but the accessible sources did not verify positive estimate revisions or a whisper edge, while the stock was in a pronounced decline into earnings; the evidence is insufficient for a surprise-oriented setup.

Headline flow is sparse and social coverage is absent. The post-print price reaction, consensus surprise, analyst revisions, and target changes are unavailable. Q2 operating results were constructive, but the going-concern warning and equity-financing dependence keep sentiment fragile and support a monitoring stance.

Primary-source sentiment is modestly negative after the Meteor termination, but the packet contains no recent news sample and no social coverage. Earnings-specific evidence, analyst reaction, and post-release price behavior remain unavailable; the $1.43 anchor is dated 2026-08-17. Zero values for social, options, short interest, and employee sentiment indicate unavailable data rather than neutral measured readings.

This is a T+1 post-earnings follow-up. The primary 8-K and stored earnings transcript support a constructive milestone update and improved runway, but the packet does not provide a verified EPS/consensus surprise, analyst target revisions, or a confirmed immediate post-print price reaction [#SEC-8K-2026-08-12] [#EARNINGS-TRANSCRIPT-2026Q2]. Low coverage and binary clinical risk favor monitoring rather than high-conviction positioning.

News tone is mixed but low-signal: contract and backlog headlines provide an operating offset to financing pressure and broader space-sector weakness. The scheduled T+1 earnings follow-up could not confirm a Q2 release, surprise, guidance change, analyst reaction, or price response. Social coverage, options data, short-interest data, and employee sentiment were not supplied; confidence remains limited.

The official company release confirms the Q3 raise and operating drivers. A secondary packet headline dated August 13 reported a 15% share-price jump after the raised forecast, but the available August 17 anchor of $37.86 does not establish whether the reaction held. Zacks context reported a slight adjusted-EPS miss and revenue beat. No post-print analyst target or estimate revisions were confirmed, and social, options, short-interest and employee-sentiment coverage are unavailable. This remains a cautious monitoring thesis rather than a high-conviction rerating call.

News tone is moderately positive, led by strong Q2 operating metrics and a positive initial market reaction. Nasdaq historical data shows the stock closed at $24.00 the day after the release versus $21.61 the prior session, then eased to $23.65 by August 17. No dated post-print analyst revision or target change was verified; missing revision data is not positive evidence. Direct operating peers ECPG and PRAA improve the comparison set, but their larger scale and different portfolio mixes limit confidence.